Suppr超能文献

标准血管内动脉瘤修复使用说明之外的主动脉颈部治疗方案比较。

Comparison of treatment options for aortic necks outside standard endovascular aneurysm repair instructions for use.

作者信息

O'Donnell Thomas F X, McElroy Imani E, Boitano Laura T, Mohebali Jahan, Lamuraglia Glenn M, Kwolek Christopher J, Conrad Mark F

机构信息

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.

出版信息

J Vasc Surg. 2021 Nov;74(5):1548-1557. doi: 10.1016/j.jvs.2021.04.052. Epub 2021 May 19.

Abstract

OBJECTIVE/BACKGROUND: Endovascular aneurysm repair (EVAR) is associated with worse outcomes in patients whose anatomy does not meet the device instructions for use (IFU). However, whether open surgical repair (OSR) and commercially available fenestrated EVAR (Zenith Fenestrated [ZFEN]) represent better options for these patients is unknown.

METHODS

We identified all patients without prior aortic surgery undergoing elective repair of abdominal aortic aneurysms with neck length ≥4 mm at a single institution with EVAR, OSR, and ZFEN. We applied device-specific aneurysm neck-related IFU to EVAR patients, and a generic EVAR IFU to ZFEN and OSR patients. Long-term outcomes were studied using propensity scores with inverse probability weighting. We compared outcomes in patients undergoing EVAR by adherence to IFU and outcomes by repair types in the subset of patients not meeting IFU.

RESULTS

Of 652 patients (474 EVAR, 34 ZFEN, 143 OSR), 211 had measurements outside of standard EVAR IFU (109 EVAR [23%], 27 ZFEN [80%], and 74 OSR [52%]). Perioperative mortality was 0.5% overall. For EVAR, treatment outside the IFU was associated with significantly higher adjusted rates of long-term type IA endoleak (22% at 5 years compared to 2% within IFU, hazard ratio [HR]: 5.8 [3.1-10.9], P < .001), and lower survival (5- and 10-year survival: 56% and 34% vs 81% and 53%, HR: 2.3 [1.2-4.3], P = .01). There was no difference in reinterventions or open conversion. In patients not meeting IFU, ZFEN was associated with higher adjusted rates of reinterventions (EVAR as referent: HR: 2.6 [1.5-4.4, P < .001), whereas OSR and EVAR patients experienced similar reintervention rates (HR: 0.7 [0.4-1.1], P = .13). Patients outside the IFU experienced lower mortality with OSR compared with either EVAR (HR: 0.4 [0.2-0.9], P = .005) or ZFEN (HR: 0.3 [0.1-0.7], P = .002). When restricted to patients outside the IFU deemed fit for open repair, OSR patients remained associated with lower adjusted mortality compared with ZFEN (HR: 0.2 [0.1-0.5], P < .001), but statistical significance was lost in the comparison to EVAR (HR: 0.6 [0.3-1.1], P = .1).

CONCLUSIONS

Treatment outside device-specific IFU is associated with adverse long-term outcomes. Open surgical repair is associated with higher long-term survival in patients who fall outside of the EVAR IFU and should be favored over EVAR or ZFEN in suitable patients. A three-vessel-based fenestrated strategy may not be a durable solution for difficult aortic necks, but more data are needed to evaluate the performance of newer, four-vessel devices.

摘要

目的/背景:对于解剖结构不符合器械使用说明(IFU)的患者,血管内动脉瘤修复术(EVAR)的预后较差。然而,开放手术修复(OSR)和市售开窗型EVAR(Zenith开窗型[ZFEN])对这些患者而言是否是更好的选择尚不清楚。

方法

我们在一家机构中确定了所有未接受过主动脉手术且拟行择期腹主动脉瘤修复术、瘤颈长度≥4 mm的患者,这些患者分别接受了EVAR、OSR和ZFEN治疗。我们对接受EVAR治疗的患者应用特定器械的与动脉瘤颈相关的IFU,对接受ZFEN和OSR治疗的患者应用通用的EVAR IFU。使用倾向评分和逆概率加权法研究长期预后。我们比较了遵循IFU的EVAR患者的预后以及未符合IFU的患者亚组中不同修复类型的预后。

结果

在652例患者(474例接受EVAR,34例接受ZFEN,143例接受OSR)中,211例患者的测量结果超出了标准EVAR IFU范围(109例接受EVAR治疗者[23%],27例接受ZFEN治疗者[80%],74例接受OSR治疗者[52%])。总体围手术期死亡率为0.5%。对于EVAR,超出IFU范围进行治疗与长期IA型内漏的校正发生率显著升高相关(5年时为22%,而符合IFU范围者为2%,风险比[HR]:5.8[3.1 - 10.9],P <.001),且生存率较低(5年和10年生存率:56%和34%,而符合IFU范围者为81%和53%,HR:2.3[1.2 - 4.3],P =.01)。再次干预或转为开放手术方面无差异。在未符合IFU的患者中,ZFEN与再次干预的校正发生率较高相关(以EVAR为对照:HR:2.6[1.5 - 4.4,P <.001]),而OSR和EVAR患者的再次干预发生率相似(HR:0.7[0.4 - 1.1],P =.13)。未符合IFU的患者中,与EVAR(HR:0.4[0.2 - 0.9],P =.005)或ZFEN(HR:0.3[0.1 - 0.7],P =.002)相比,OSR患者的死亡率较低。当仅限于被认为适合开放修复的未符合IFU的患者时,与ZFEN相比,OSR患者仍与较低的校正死亡率相关(HR:0.2[0.1 - 0.5],P <.001),但与EVAR比较时统计学显著性消失(HR:0.6[0.3 - 1.1],P =.1)。

结论

超出特定器械IFU范围进行治疗与不良的长期预后相关。对于不符合EVAR IFU的患者,开放手术修复与较高的长期生存率相关,在合适的患者中应优先于EVAR或ZFEN。基于三分支的开窗策略对于困难的主动脉瘤颈可能不是一个持久的解决方案,但需要更多数据来评估更新的四分支器械的性能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验